Form 4 Filing for Eli Lilly & Co.

Gabrielle Sulzberger, a director at Eli Lilly & Co. (LLY), acquired 4.3904 shares of common stock on June 15, 2026. The acquisition was made at a price of $1129.35 per share, resulting in a post-transaction ownership of 2995.3956 shares. These shares were acquired in lieu of cash compensation and have been deferred as stock units under the Lilly Directors' Deferral Plan, to be settled in shares of common stock after Sulzberger's separation from service. The filing was signed by Jonathan Groff on behalf of Gabrielle Sulzberger on June 16, 2026.